1,265 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B Downtrend
Article Searches
Change In Leadership For NASH Coming http://seekingalpha.com/article/4052381-change-leadership-nash-coming?source=feed_tag_editors_picks Mar 06, 2017 - Regulatory themes will shape the lead in NASH.Clinical trials with the Right endpoint are more important than the trial Phase when determining the leader.Galectin-3 is implicated in the progression of
Biotech Bonanza: Breaking New Ground And More To Go http://seekingalpha.com/article/4052320-biotech-bonanza-breaking-new-ground-go?source=feed_all_articles Mar 06, 2017 - Biotechnology finally recorded a 52-week high, lagging the broader market by 8 months.Early stages of the rally, with multiple reasons to drive further new highs in the months ahead.Key drivers appear
Industry Snapshot: Setting Sights On Glaucoma Drug Makers http://seekingalpha.com/article/4052023-industry-snapshot-setting-sights-glaucoma-drug-makers?source=feed_sector_healthcare Mar 03, 2017 - Degenerative eye disease glaucoma has a market over $5 billion and growing with aging population. Current key drugs from Allergan, Merck, and Pfizer offer varied efficacy and limited mechanisms of act
FDA OKs first treatment for nocturnal polyuria http://seekingalpha.com/news/3248633-fda-oks-first-treatment-nocturnal-polyuria?source=feed_news_all Mar 03, 2017 - The FDA approves privately held Serenity Pharmaceuticals' Noctiva (desmopressin) nasal spray for the treatment of adults with nocturnal polyuria (overproduction of urine at night), the first such appr
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , Sells ... http://www.gurufocus.com/news/489259/saba-capital-management-lp-buys-allergan-plc-alpine-total-dynamic-dividend-fund--sells-blackrock-debt-strategies-fund-western-asset-emerging-markets-debt-fund-ishares-china-largecap Mar 03, 2017 - Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, , Sells Blackrock Debt Strategies Fund, Western Asset Emerging Markets Debt Fund, iShares China Large-Cap, Stocks: FSD,GLO,CYH,DEX,VRX,USA,AGN,AOD,ESD,GLQ,GLV,OMF,BG, release date:Mar 03, 2017
Biotech Forum Daily Digest: Upward Resistance Levels Continue To Hold; Spotlight On Foamix Pharmaceuticals https://seekingalpha.com/article/4051861-biotech-forum-daily-digest-upward-resistance-levels-continue-hold-spotlight-foamix?source=feed_tag_israel Mar 03, 2017 - The biotech sector tried once again to breach upward resistance levels that have been in place for over a year on Thursday, but failed once again to meaningfully break through. A couple of small cap n
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ... http://www.gurufocus.com/news/488966/north-tide-capital-llc-buys-impax-laboratories-allergan-plc-accuray-sells-community-health-systems-valeant-pharmaceuticals-international-mylan-nv Mar 02, 2017 - North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health Systems, Valeant Pharmaceuticals International, Mylan NV, Stocks: IPXL,AGN,ARAY,MYL,SEM,SVU,GILD,CYH,VRX,PRGO,AFAM,A, release date:Mar 02, 2017
Valeant: Probably Worthless, Or Risky But Attractive Now? http://seekingalpha.com/article/4051533-valeant-probably-worthless-risky-attractive-now?source=feed_tag_short_ideas Mar 02, 2017 - Valeant has dropped from well above $250 1 1/2 years ago to below $14.Yet its debt load still is far above $25 B, and using Generally Accepted Accounting Principles, yoy EPS worsened in Q4.This articl
Pharmaceutical Stocks Are Ready To Rally - Cramer's Mad Money (3/1/17) http://seekingalpha.com/article/4051408-pharmaceutical-stocks-ready-rally-cramers-mad-money-3-1-17?source=feed_tag_cramers_picks Mar 02, 2017 - Market has changed its stance after Trump's speech.Emcor and MasTec will benefit from investments in infrastructure.Don't buy Polo Ralph Lauren as apparel group is in trouble.
Jerome Dodson Adds to 9 Positions in 4th Quarter http://www.gurufocus.com/news/488726/jerome-dodson-adds-to-9-positions-in-4th-quarter Mar 01, 2017 - Jerome Dodson Adds to 9 Positions in 4th Quarter, Stocks: AGN,MCK,PGR,GILD,KLAC,ADS,PNR,AXTA,PDCO, Jerome Dodson,Vanguard Health Care Fund,PRIMECAP M, release date:Mar 01, 2017

Pages: 1...8788899091929394959697...127

<<<Page 92>